Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:460789rdf:typepubmed:Citationlld:pubmed
pubmed-article:460789lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:460789lifeskim:mentionsumls-concept:C0237865lld:lifeskim
pubmed-article:460789lifeskim:mentionsumls-concept:C1539916lld:lifeskim
pubmed-article:460789lifeskim:mentionsumls-concept:C1579762lld:lifeskim
pubmed-article:460789lifeskim:mentionsumls-concept:C0009491lld:lifeskim
pubmed-article:460789pubmed:issue2lld:pubmed
pubmed-article:460789pubmed:dateCreated1979-9-25lld:pubmed
pubmed-article:460789pubmed:abstractTextTA3/Ha and TA3/St sublines differ from each other in some characteristics, like malignancy, survival time and drug sensitivity. TA3/St exhibited a peculiar response to the Vinca derivatives examined.lld:pubmed
pubmed-article:460789pubmed:languageenglld:pubmed
pubmed-article:460789pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:460789pubmed:citationSubsetIMlld:pubmed
pubmed-article:460789pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:460789pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:460789pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:460789pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:460789pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:460789pubmed:statusMEDLINElld:pubmed
pubmed-article:460789pubmed:issn0030-2414lld:pubmed
pubmed-article:460789pubmed:authorpubmed-author:SugárJJlld:pubmed
pubmed-article:460789pubmed:authorpubmed-author:GálFFlld:pubmed
pubmed-article:460789pubmed:authorpubmed-author:SusanS RSRlld:pubmed
pubmed-article:460789pubmed:issnTypePrintlld:pubmed
pubmed-article:460789pubmed:volume36lld:pubmed
pubmed-article:460789pubmed:ownerNLMlld:pubmed
pubmed-article:460789pubmed:authorsCompleteYlld:pubmed
pubmed-article:460789pubmed:pagination84-8lld:pubmed
pubmed-article:460789pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-A...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-M...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-F...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-A...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-A...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-A...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-M...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-A...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-A...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-C...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-D...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-M...lld:pubmed
pubmed-article:460789pubmed:meshHeadingpubmed-meshheading:460789-V...lld:pubmed
pubmed-article:460789pubmed:year1979lld:pubmed
pubmed-article:460789pubmed:articleTitleComparative study on drug sensitivity of the TA3/Ha and TA3/St tumor sublines.lld:pubmed
pubmed-article:460789pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:460789pubmed:publicationTypeComparative Studylld:pubmed